Environmental, Social And Governance Report

Overview

The report highlights Ascentage Pharma's transition from R&D toward production, including its first NDA submission and a 12-candidate clinical pipeline. It records more than 40 Phase I or II clinical trials and 11 FDA Orphan Drug Designations. The company reported zero work-related fatalities or injuries and total 2020 GHG emissions of 959.27 ton of CO2 equivalent. It also reports 7,013.5 hours of employee training, averaging 16.2 hours per employee.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2020
Period: 1 January 2020 – 31 December 2020
Publication date: 21 June 2021
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services